Notice of Suspension of E-cigarette Business by Shenzhen KangerTech

Regulations by 2FIRSTS.ai
May.09.2024
Notice of Suspension of E-cigarette Business by Shenzhen KangerTech
The State Tobacco Monopoly Administration announced that Shenzhen KangerTech Co., Ltd. has ceased e-cigarette operations for over six months.

Recently, the State Tobacco Monopoly Administration announced that Shenzhen KangerTech Co., Ltd. has ceased its e-cigarette related business operations.

 

The announcement is as follows:

 

Shenzhen KangerTech Technology Co., Ltd., License Number: 5144030097, legal representative (responsible person): Ke Songfang, business address (main operating location): 12th floor, 67 District, Daqian Industrial Park, Xingdong Community, Baoan District, Shenzhen, has ceased operations for more than six months without filing for closure procedures. In accordance with Article 50 of the "Tobacco Monopoly License Management Measures", this notice is hereby given for a period of one month. Enterprises are requested to go to the provincial tobacco monopoly bureau at the business address (main operating location) during the notice period to complete closure procedures or resume operations. If overdue, our bureau will lawfully revoke the tobacco monopoly production enterprise permit held by the company.

 

Hereby announce.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Asia Pacific Harm Reduction Alliance Criticizes Singapore’s Policy: Confusing Illegal “Drug Pods” with Legal E-Cigarettes May Fuel Black Market Circulation
Asia Pacific Harm Reduction Alliance Criticizes Singapore’s Policy: Confusing Illegal “Drug Pods” with Legal E-Cigarettes May Fuel Black Market Circulation
The Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA) has expressed concern over Singapore Prime Minister Lawrence Wong’s recent announcement to treat e-cigarettes as a “drug issue” and impose imprisonment penalties. CAPHRA stated that this policy confuses illegal products containing etomidate with legal nicotine devices, goes against harm reduction science, deprives adult smokers of access to safer alternatives, and may instead fuel black market circulation.
Aug.19 by 2FIRSTS.ai
Malaysian Authorities Seize $30,000 Worth of Vape Products; 43-Year-Old Man Under Investigation
Malaysian Authorities Seize $30,000 Worth of Vape Products; 43-Year-Old Man Under Investigation
Malaysian GOF seized 1,242 bottles of vape liquid and 36 boxes of devices worth RM125,000 ($30,000) in Tanah Merah. A 43-year-old man is under investigation for lacking valid documents and storage permits. The case is being processed under MDTM regulations.
Jul.23 by 2FIRSTS.ai
2Firsts Exclusive with Former WHO Director Tikki Pang: FCTC Overlooks Tobacco Harm Reduction, and Asia’s Tobacco Control Challenges Demand Urgent Solutions
2Firsts Exclusive with Former WHO Director Tikki Pang: FCTC Overlooks Tobacco Harm Reduction, and Asia’s Tobacco Control Challenges Demand Urgent Solutions
Ahead of AFN25, 2Firsts interviewed former WHO director Tikki Pang, who reflected on two decades of the FCTC. While acknowledging its early successes, Pang pointed to its greatest shortcoming—excluding tobacco harm reduction—and noted its limited impact in Asia. He called for advancing THR and emphasized that proper regulation should balance reducing risks for adults and preventing youth access, while ensuring affordability and curbing illicit trade.
Aug.26
Although not yet approved by the FDA, Altria still plans to launch its new nicotine pouch product, on! PLUS™, in the U.S
Although not yet approved by the FDA, Altria still plans to launch its new nicotine pouch product, on! PLUS™, in the U.S
Altria announced that its subsidiary, Helix, will launch a new nicotine pouch product, on! PLUS™, in the U.S. this fall, with the initial markets covering North Carolina, Texas, and Florida. The product has not yet been approved by the FDA. It is noteworthy that the launch time and regions for on! PLUS™ are highly similar to those of BAT's planned disposable e-cigarette, Vuse One.
Aug.25
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
Reuters: The US FDA, under pressure from the White House, will complete its review of nicotine pouches such as ZYN, VELO, and on! by the end of December
The U.S. FDA will launch a pilot program to accelerate reviews of nicotine pouch products from Philip Morris International, Altria, BAT’s Reynolds American, and Turning Point Brands, aiming to complete the process by December 2025. The move, driven by pressure from the Trump administration, seeks to address past multi-year approval delays. Nicotine pouches, the fastest-growing U.S. smoking alternative, are seen as lower-risk but raise youth appeal concerns.
Sep.08
China’s STMA Issues Draft Rules on Domestic Duty-Free Tobacco: Mandating Traceability and Banning Sales of New Tobacco Products
China’s STMA Issues Draft Rules on Domestic Duty-Free Tobacco: Mandating Traceability and Banning Sales of New Tobacco Products
China’s STMA has issued draft measures to tighten control of duty-free tobacco from 2026, expanding scope, enforcing quotas, digital traceability, and banning e-cigarettes and HTPs.
Jul.28